Want to see MWAI full AI Analyst Report?
Top Page
MedWellAI
(OTC:MWAI)
Select Model
Select Model
Rating:42Neutral
Price Target:
$0.27
▼(-23.43% Downside)
Action:Reiterated
Date:10/22/26
The score is primarily held down by weak financial performance—sharp revenue contraction, ongoing large losses, continued cash burn, and negative equity that elevates solvency and financing risk. Technicals also lean bearish with the price below key moving averages and negative MACD, while valuation support is limited because losses make the negative P/E less informative and no dividend yield is available.
Positive Factors
AI Healthcare Focus
MedWellAI is positioned in the digital-health and AI software sectors, applying artificial intelligence to medical and wellness workflows. This gives the company exposure to technology adoption in healthcare and a model that can potentially scale through software-based tools and services.
Negative Factors
Severe Revenue Contraction
A 63.2% annual revenue decline and highly volatile sales materially weaken the company’s operating base. Lower revenue reduces the ability to absorb fixed costs, makes profitability harder to reach, and raises uncertainty about whether the current business model can produce dependable growth.
Read all positive and negative factors
Positive Factors
Negative Factors
AI Healthcare Focus
MedWellAI is positioned in the digital-health and AI software sectors, applying artificial intelligence to medical and wellness workflows. This gives the company exposure to technology adoption in healthcare and a model that can potentially scale through software-based tools and services.
Read all positive factors
MedWellAI (MWAI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.94M
Dividend YieldN/A
Average Volume (3M)1.88K
Price to Earnings (P/E)―
Beta (1Y)0.82
Revenue Growth-5.68%
EPS Growth60.23%
CountryUS
Employees5
SectorFinancial
Sector Strength70
IndustryFinancial - Capital Markets
Share Statistics
EPS (TTM)-0.24
Shares Outstanding6,536,580
10 Day Avg. Volume4,630
30 Day Avg. Volume1,879
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.23
Price to Sales (P/S)3.43
P/FCF Ratio-5.75
Enterprise Value/Market Cap1.06M
Enterprise Value/Revenue3.92M
Enterprise Value/Gross Profit5.92M
Enterprise Value/Ebitda-1.78M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MedWellAI Business Overview & Revenue Model
Company Description
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, p...
MedWellAI Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
15
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 527.86K | 594.77K | 5.86M | 5.86M | 3.86M |
| Gross Profit | 496.83K | 586.67K | 1.93M | 1.93M | 1.16M |
| EBITDA | -1.16M | -2.87M | -8.61M | -21.59M | 1.07M |
| Net Income | -1.59M | -3.61M | -11.52M | -11.52M | -565.51K |
Balance Sheet | |||||
| Total Assets | 140.45K | 805.50K | 3.94M | 6.59M | 16.28M |
| Cash, Cash Equivalents and Short-Term Investments | 86.22K | 401.31K | 57.81K | 258.00K | 490.28K |
| Total Debt | 500.00K | 604.27K | 500.00K | 500.00K | 385.44K |
| Total Liabilities | 7.96M | 3.14M | 7.81M | 7.10M | 5.69M |
| Stockholders Equity | -7.98M | -2.50M | -3.87M | -509.88K | 10.59M |
Cash Flow | |||||
| Free Cash Flow | -315.09K | -937.55K | -4.13M | -3.73M | -9.88M |
| Operating Cash Flow | -307.03K | -935.31K | -4.13M | -3.43M | 55.45K |
| Investing Cash Flow | -8.06K | 1.19M | 4.17M | 4.17M | -2.27M |
| Financing Cash Flow | 0.00 | 0.00 | -243.15K | -243.15K | 604.92K |
MedWellAI Technical Analysis
Neutral
0.35
Price Trends
0.31
Negative
0.31
Negative
0.36
Negative
Market Momentum
>-0.01
Negative
49.59
Neutral
90.82
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MWAI, the sentiment is Neutral. The current price of 0.35 is above the 20-day moving average (MA) of 0.30, above the 50-day MA of 0.31, and below the 200-day MA of 0.36, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 49.59 is Neutral, neither overbought nor oversold. The STOCH value of 90.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MWAI.
MedWellAI Risk Analysis
MedWellAI disclosed 12 risk factors in its most recent earnings report. MedWellAI reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
MedWellAI Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
46 Neutral | $39.94M | -8.68 | -20.95% | ― | 22.98% | -362.10% | |
43 Neutral | $1.64M | >-0.01 | 78.82% | ― | -96.21% | -112.17% | |
42 Neutral | $1.94M | -1.22 | 21.06% | ― | -5.68% | 60.23% | |
42 Neutral | $2.00M | -0.16 | -138.21% | ― | 117.68% | -0.39% |
* Financial Sector Average
MWAI
MedWellAI
0.30
-0.46
-60.77%
AIXI
Xiao-I Corp. ADR
2.90
-155.30
-98.17%
SPPL
Simpple Ltd.
2.15
-4.01
-65.10%
HIT
Health In Tech, Inc. Class A
0.61
-2.00
-76.59%
CSAI
Cloudastructure, Inc. Class A
2.29
-40.01
-94.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.